Home › Overweight › Florida › Davie
Overweight clinical trials in Davie, FL
6 studies for Overweight are looking for participants at sites in and around Davie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 2
- Encore Medical Research - Weston /ID# 282044, Weston · 11 mi away
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- Encore Medical Research of Weston, Weston · 11 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Encore Medical Research of Weston LLC, Weston · 11 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Encore Medical Research of Weston LLC, Weston · 11 mi away
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RecruitingPhase 3
- Encore Medical Research of Weston, Weston · 11 mi away
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RecruitingPhase 1
- Encore Medical Research of Weston, Weston · 11 mi away
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Davie
- Breast Cancer7 studies
- Obesity6 studies
- Heart Failure6 studies
- Cancer (all types)5 studies
- Type 2 Diabetes4 studies
- Interstitial Lung Diseases4 studies
- Amyotrophic Lateral Sclerosis4 studies
- Non-Small Cell Lung Cancer4 studies
- Cardiogenic Shock3 studies
- Cardiovascular Disease3 studies
- Renal Insufficiency3 studies
- Lupus3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.